San Leandro, CALIFORNIA1 Active Studies

Substance Use Disorder Clinical Trials in San Leandro, CALIFORNIA

Find 1 actively recruiting substance use disorder clinical trials in San Leandro, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
360
Enrolling

Recruiting Substance Use Disorder Studies in San Leandro

About Substance Use Disorder Clinical Trials in San Leandro

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in San Leandro, CALIFORNIA. These studies are seeking a combined 360 participants. Research is being sponsored by Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in San Leandro — FAQ

Are there substance use disorder clinical trials in San Leandro?

Yes, there are 1 substance use disorder clinical trials currently recruiting in San Leandro, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Leandro?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Leandro research site will contact you about next steps.

Are clinical trials in San Leandro free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Leandro studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in San Leandro are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov